{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:27:00Z","timestamp":1767922020800,"version":"3.49.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Interventions requiring a PICU are rare in toxicologic exposures, but cardiovascular medications are high-risk exposures due to their hemodynamic effects. This study aimed to describe prevalence of and risk factors for PICU interventions among children exposed to cardiovascular medications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Secondary analysis of Toxicology Investigators Consortium Core Registry from January 2010 to March 2022.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>International multicenter research network of 40 sites.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients 18 years old or younger with acute or acute-on-chronic toxicologic exposure to cardiovascular medications. Patients were excluded if exposed to noncardiovascular medications or if symptoms were documented as unlikely related to exposure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Of 1,091 patients in the final analysis, 195 (17.9%) received PICU intervention. One hundred fifty-seven (14.4%) received intensive hemodynamic interventions and 602 (55.2%) received intervention in general. Children less than 2 years old were less likely to receive PICU intervention (odds ratio [OR], 0.42; 95% CI, 0.20\u20130.86). Exposures to alpha-2 agonists (OR, 2.0; 95% CI, 1.11\u20133.72) and antiarrhythmics (OR, 4.26; 95% CI, 1.41\u201312.90) were associated with PICU intervention. In the sensitivity analysis removing atropine from the composite outcome PICU intervention, only exposures to calcium channel antagonists (OR, 2.12; 95% CI, 1.09\u20134.11) and antiarrhythmics (OR, 4.82; 95% CI, 1.57\u201314.81) were independently associated with PICU intervention. No independent association was identified between PICU intervention and gender, polypharmacy, intentionality or acuity of exposure, or the other medication classes studied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>PICU interventions were uncommon but were associated with exposure to antiarrhythmic medications, calcium channel antagonists, and alpha-2 agonists. As demonstrated via sensitivity analysis, exact associations may depend on institutional definitions of PICU intervention. Children less than 2 years old are less likely to require PICU interventions. In equivocal cases, age and exposure to certain cardiovascular medication classes may be useful to guide appropriate disposition.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003274","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T14:00:05Z","timestamp":1683122405000},"page":"893-900","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Intensive Care Interventions Among Children With Toxicologic Exposures to Cardiovascular Medications"],"prefix":"10.1097","volume":"24","author":[{"given":"Michael D.","family":"Simpson","sequence":"first","affiliation":[{"name":"Harvard Medical Toxicology Program, Division of Emergency Medicine, Boston Children\u2019s Hospital, Boston, MA."},{"name":"Department of Emergency Medicine, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. James","family":"Watson","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Maine Medical Center, Portland, ME."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Whitledge","sequence":"additional","affiliation":[{"name":"Harvard Medical Toxicology Program, Division of Emergency Medicine, Boston Children\u2019s Hospital, Boston, MA."},{"name":"Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Monuteaux","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele M.","family":"Burns","sequence":"additional","affiliation":[{"name":"Harvard Medical Toxicology Program, Division of Emergency Medicine, Boston Children\u2019s Hospital, Boston, MA."},{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Toxicology Investigators Consortium (ToxIC)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1056\/NEJMc2201761","article-title":"Current causes of death in children and adolescents in the United States.","volume":"386","author":"Goldstick","year":"2022","journal-title":"N Engl J Med"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1080\/15563650.2021.1989785","article-title":"2020 Annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 38th annual report.","volume":"59","author":"Gummin","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/15563650.2019.1634272","article-title":"Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures.","volume":"58","author":"Carreiro","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00003246-198908000-00005","article-title":"Admission to a pediatric intensive care unit for poisoning: A review of 105 cases.","volume":"17","author":"Lacroix","year":"1989","journal-title":"Crit Care Med"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1542\/peds.77.2.144","article-title":"Acute poisoning in a children\u2019s hospital: A 2-year experience.","volume":"77","author":"Fazen","year":"1986","journal-title":"Pediatrics"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/15563650.2014.909601","article-title":"Poisonings requiring admission to the pediatric intensive care unit: A 5-year review.","volume":"52","author":"Even","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1097\/PCC.0000000000001187","article-title":"Analysis of interventions required in 12,021 children with acute intoxications admitted to PICUs.","volume":"18","author":"Patel","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s13181-022-00910-6","article-title":"The toxicology investigators consortium case registry-the 2021 annual report.","volume":"18","author":"Love","year":"2022","journal-title":"J Med Toxicol"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/15563650.2021.1891244","article-title":"Clinical and patient characteristics associated with severe outcome in diphenhydramine toxicity.","volume":"59","author":"Hughes","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/15563650.2020.1746330","article-title":"Drug-specific risk of severe QT prolongation following acute drug overdose.","volume":"58","author":"Campleman","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1080\/15563650.2022.2059497","article-title":"Critical care interventions in children aged 6 months to 12 years admitted to the pediatric intensive care unit after unintentional cannabis exposures.","volume":"60","author":"Leonard","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1542\/hpeds.2012-0081","article-title":"Clinical profile of children requiring early unplanned admission to the PICU.","volume":"3","author":"Krmpotic","year":"2013","journal-title":"Hosp Pediatr"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/15563650.2019.1676896","article-title":"Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: A retrospective study of the Extracorporeal Life Support Organizations\u2019 ECMO case registry.","volume":"58","author":"Weiner","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/15563650.2020.1752918","article-title":"Treatment for beta-blocker poisoning: A systematic review.","volume":"58","author":"Rotella","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1097\/CCM.0000000000002087","article-title":"Experts consensus recommendations for the management of calcium channel blocker poisoning in adults.","volume":"45","author":"St-Onge","year":"2017","journal-title":"Crit Care Med"},{"key":"R16-20250502","first-page":"251","article-title":"Thirty-three-year experience on childhood poisoning.","volume":"54","author":"Ozdemir","year":"2012","journal-title":"Turk J Pediatr"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s13181-019-00738-7","article-title":"Pediatric bupropion ingestions in adolescents vs. younger children-a tale of two populations.","volume":"16","author":"Offerman","year":"2020","journal-title":"J Med Toxicol"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.3928\/19382359-20171121-01","article-title":"Pediatric poisoning by ingestion: Developmental overview and synopsis of national trends.","volume":"46","author":"Lee","year":"2017","journal-title":"Pediatr Ann"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0736-4679(00)00266-3","article-title":"Fatal nifedipine ingestions in children.","volume":"19","author":"Lee","year":"2000","journal-title":"J Emerg Med"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jemermed.2007.02.010","article-title":"Are one or two dangerous? Calcium channel blocker exposure in toddlers.","volume":"33","author":"Ranniger","year":"2007","journal-title":"J Emerg Med"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/15563650.2021.1960683","article-title":"Pediatric beta-adrenergic antagonist ingestions reported to the National Poison Data System, 2000-2020. In: North American Congress of Clinical Toxicology (NACCT) abstracts 2021.","volume":"59","author":"Watson","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jemermed.2003.11.015","article-title":"Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers.","volume":"26","author":"Love","year":"2004","journal-title":"J Emerg Med"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/pubmed\/fdab339","article-title":"Analysis of ingestion admissions in a midsized pediatric intensive care unit.","volume":"44","author":"Smith","year":"2022","journal-title":"J Public Health"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/0885066617754046","article-title":"Outcomes and costs of patients admitted to the intensive care unit due to accidental or intentional poisoning.","volume":"35","author":"Fernando","year":"2020","journal-title":"J Intensive Care Med"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12873-019-0224-7","article-title":"The healthcare costs of intoxicated patients who survive ICU admission are higher than non-intoxicated ICU patients: A retrospective study combining healthcare insurance data and data from a Dutch national quality registry.","volume":"19","author":"van Beusekom","year":"2019","journal-title":"BMC Emerg Med"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jemermed.2020.09.018","article-title":"Clinical effects of pediatric clonidine exposure: A retrospective cohort study at a single tertiary care center.","volume":"60","author":"Toce","year":"2021","journal-title":"J Emerg Med"},{"key":"R27-20250502","first-page":"e459","article-title":"Pediatric pharmaceutical ingestions.","volume":"46","author":"Lowry","year":"2017","journal-title":"Pediatr Ann"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0974-2069.180671","article-title":"Amiodarone toxicity: An underdiagnosed entity.","volume":"9","author":"Xavier","year":"2016","journal-title":"Ann Pediatr Cardiol"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"1840.e3","DOI":"10.1016\/j.ajem.2015.04.012","article-title":"Life-threatening flecainide overdose treated with intralipid and extracorporeal membrane oxygenation.","volume":"33","author":"Brumfield","year":"2015","journal-title":"Am J Emerg Med"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:18:03Z","timestamp":1746206283000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003274","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,3]]}}}